VivoSim Labs (FRA:4OR) OCF Margin %: -8,813.64% (As of Dec. 2025)

What is VivoSim Labs OCF Margin %?

VivoSim Labs FRA:4OR 39 OCF Margin % is -8,813.64% as of Dec. 2025. GuruFocus rates FRA:4OR with a GF Score™ of 39/100 and a GF Value™ of €8.13. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, VivoSim Labs ranks worse than 93.01% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. VivoSim Labs's Cash Flow from Operations for the three months ended in Dec. 2025 was €-1.94 Mil. VivoSim Labs's Revenue for the three months ended in Dec. 2025 was €0.02 Mil. Therefore, VivoSim Labs's OCF Margin % for the quarter that ended in Dec. 2025 was -8,813.64%.

As of today, VivoSim Labs's current OCF Yield % is -324.79%.

The historical rank and industry rank for VivoSim Labs's OCF Margin % or its related term are showing as below:

FRA:4OR' s OCF Margin % Range Over the Past 10 Years
Min: -13443.12 Med: -689.95 Max: -563.53
Current: -7410.4

During the past 13 years, the highest OCF Margin % of VivoSim Labs was -563.53%. The lowest was -13443.12%. And the median was -689.95%.

FRA:4OR's OCF Margin % is ranked worse than
93.01% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs FRA:4OR: -7410.40

VivoSim Labs OCF Margin % Related Terms

VivoSim Labs OCF Margin % Historical Data

* Premium members only.

The historical data trend for VivoSim Labs's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VivoSim Labs OCF Margin % Chart

VivoSim Labs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

OCF Margin %

Get a 7-Day Free Trial

0.00

-563.51

-3,349.42

-13,481.00

-6,579.70

VivoSim Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
OCF Margin %	Get a 7-Day Free Trial															-7,478.26	-4,004.26	-10,675.00	-8,441.67	-8,813.64

FRA:4OR vs AZTR, GRI, BIXT: OCF Margin % Comparison

For the Biotechnology subindustry, VivoSim Labs's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VivoSim Labs OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VivoSim Labs's OCF Margin % distribution charts can be found below:

* The bar in red indicates where VivoSim Labs's OCF Margin % falls into.

Save Embed

39GF Score

VivoSim Labs Inc FRA:4OR

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

VivoSim Labs OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

VivoSim Labs's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Mar. 2025 )	/	Revenue (A: Mar. 2025 )
	=	-8.751	/	0.133
	=	-6,579.70 %

VivoSim Labs's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-1.939	/	0.022
	=	-8,813.64 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -8,813.64% mean?

VivoSim Labs (FRA:4OR) has a OCF Margin % of -8,813.64% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on VivoSim Labs and its competitors. According to the industry distribution chart, VivoSim Labs ranks #892 out of 959 companies in the Biotechnology industry, placing it in the top 93%.

Is VivoSim Labs' OCF Margin % too high?

VivoSim Labs' current OCF Margin % is -8,813.64%. Based on the distribution chart, VivoSim Labs ranks #892 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, VivoSim Labs has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.

How does VivoSim Labs' OCF Margin % compare to AZTR and GRI?

According to the Biotechnology industry distribution chart, VivoSim Labs ranks #892 out of 959 companies for OCF Margin %. This places VivoSim Labs in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on VivoSim Labs and its competitors. VivoSim Labs's current OCF Margin % is -8,813.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is VivoSim Labs stock overvalued right now?

VivoSim Labs (FRA:4OR) has a current OCF Margin % of -8,813.64%. The stock's GF Value™ is €8.13, compared to a current price of €3.49 — trading 57% below its estimated fair value. The current OCF Margin % is -8,813.64%. VivoSim Labs' overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For VivoSim Labs (FRA:4OR), the current OCF Margin % is -8,813.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is VivoSim Labs (FRA:4OR) Overvalued in 2026?

Based on GuruFocus' analysis, VivoSim Labs stock appears to be undervalued. The current stock price of €3.49 is trading 57% below its estimated GF Value™ of €8.13.

Key valuation signals for FRA:4OR:

OCF Margin %: -8,813.64%
GF Value™: €8.13 vs. price of €3.49 (57% below fair value)
GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the FRA:4OR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

VivoSim Labs Business Description

Industry Healthcare Biotechnology

Comparable Companies AZTR GRI BIXT CMND SXTP CLDI LSBCF ACUT PPCB ENSC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges VIVS:USA

Address 11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website https://www.organovo.com

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

39GF Score

Get the complete analysis for FRA:4OR

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.49

Price

€8.13

GF Value

View FRA:4OR Analysis

See OCF Margin % data for all stocks →